It works better and faster than before.

From Ninja Cat to named owners — I learned how Microsoft is rebooting the Insider program to restore trust, but will it work? When you purchase through links on our site, we may earn an affiliate ...

AI thrives on data but feeding it the right data is harder than it seems. As enterprises scale their AI initiatives, they face the challenge of managing diverse data pipelines, ensuring proximity to ...

In this post, we will show you how to change the starting Default Directory that opens when you launch Command Prompt on a Windows 11 PC. When you open Command Prompt (CMD), it usually starts in the ...

If you have found Windows 11's feature rollouts confusing, Microsoft hears you and is overhauling the Windows Insider Program. Now, instead of three Insider channels, there are just two: Experimental ...

When the IBM PC was new, I served as the president of the San Francisco PC User Group for three years. That’s how I met PCMag’s editorial team, who brought me on board in 1986. In the years since that ...

Something to look forward to: Microsoft released new Windows 11 Insider Preview builds to the Canary, Dev, and Beta channels this week, bringing multiple new features for developers and power users.

As TSA lines get longer and the situation at U.S. airports becomes more uncertain, there's a method for flyers hoping to fast-pass security wait times. In addition to keeping tabs on TSA wait-time ...

Sometimes when something breaks in Windows, I skip the Settings app and go straight to Command Prompt. Five built-in commands handle the bulk of common problems - repairing corrupted system files, ...

Remember the good old days of 2020 when Apple’s then-new M1 Macs were setting fresh records for Mac performance? You might also recall when those same Macs were described as being the fastest PCs to ...

Microsoft and Apple have long felt like the Montagues and the Capulets, but lately, it feels like that feud is gradually mellowing into a cordial, mutual understanding — without needing two young ...

Two new cancer cases have prompted Kyowa Kirin to shutter all clinical studies of its investigational anti-OX40 monoclonal antibody designed to treat inflammatory diseases. The discontinuation will ...